
Ne treba paničariti, dakle. Bilo koje cjepivo poslužit će svrsi.
EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of 18 March 2021. The Committee confirmed that:
- the benefits of the vaccine in combating the still widespread threat of COVID-19 (which itself results in clotting problems and may be fatal) continue to outweigh the risk of side effects;
- the vaccine is not associated with an increase in the overall risk of blood clots (thromboembolic events) in those who receive it;
- there is no evidence of a problem related to specific batches of the vaccine or to particular manufacturing sites;
- however, the vaccine may be associated with very rare cases of blood clots associated with thrombocytopenia, i.e. low levels of blood platelets (elements in the blood that help it to clot) with or without bleeding, including rare cases of clots in the vessels draining blood from the brain (CVST).
Bolest se potvrđuje različitim metodama. Osim serološkog testiranja (kojim se mjeri prisutnost IgM i IgG antitijela), postoji i PCR testiranje (kojim se utvrđuje prisutnost ili odsutnost CoV-2 genoma), kao i antigensko testiranje (kojim se dokazuje prisutnost ili odsutnost virusnih proteina; uglavnom je posrijedi nukleokapsidni protein). Sve imaju određenih nedostataka, npr. PCR i ekvivalenti testovima nukleinske kiseline smatraju se najpouzdanijim načinom za određivanje nosi li osoba SARS-CoV-2, ali ne zna se je li ona zarazna ili nije.
Ne znam što je 'to', al neka si dočekaoStitch wrote:Bravo, to sam čekao.
Users browsing this forum: CCBot and 0 guests